Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID, 75,"Kurz SG, et al., Endocrinology. 2008 Apr 17",mammary gland integrity trait,,RS:0000032,ACI/SegHsd,female,259 days to 0 days,21,,CMO:0000345,post-insult time to mammary tumor formation,,median,,145,d,,,MMO:0000158,manual palpation method,,0,,,,,17 beta-estradiol (27.5 mg) (for 196 days),11375,17 beta-estradiol (27.5 mg) (for 196 days) 81,"Schaffer BS, et al., Cancer Res. 2006 Aug 1;66(15):7793-800",mammary gland integrity trait,,RS:0000032,ACI/SegHsd,female,259 days to 143 days,22,,CMO:0000345,post-insult time to mammary tumor formation,,,,136,d,6.0,28.1425,MMO:0000158,manual palpation method,,0.0,,crystalline implant,,,17 beta-estradiol (27.5 mg) (between 193 and 199 days),11383,17 beta-estradiol (27.5 mg) (between 193 and 199 days) 144,"Shull JD, et al., Endocrinology 2001 Dec;142(12):5124-30",mammary gland integrity trait,,RS:0000032,ACI/SegHsd,female,264 days to 206 days,31,,CMO:0000345,post-insult time to mammary tumor formation,,mean,,141,d,4.8493,27.0,MMO:0000158,manual palpation method,,,,,,,17 beta-estradiol (27.5 mg) (between 147 and 195 days),11748,17 beta-estradiol (27.5 mg) (between 147 and 195 days) 144,"Shull JD, et al., Endocrinology 2001 Dec;142(12):5124-30",mammary gland integrity trait,,RS:0000032,ACI/SegHsd,female,264 days to 206 days,31,,CMO:0000345,post-insult time to mammary tumor formation,,median,median,140,d,,,MMO:0000158,manual palpation method,,,,,,,17 beta-estradiol (27.5 mg) (between 147 and 195 days),11750,17 beta-estradiol (27.5 mg) (between 147 and 195 days) 76,"Shull JD, et al., Carcinogenesis. 1997 Aug;18(8):1595-601",mammary gland integrity trait,,RS:0000032,ACI/SegHsd,female,260 days to 160 days,21,,CMO:0000345,post-insult time to mammary tumor formation,,,serial mean,145,d,,,MMO:0000158,manual palpation method,mammary gland,0.0,,,,,17 beta-estradiol (27.5 mg) (between 99 and 197 days),66104,17 beta-estradiol (27.5 mg) (between 99 and 197 days) 76,"Shull JD, et al., Carcinogenesis. 1997 Aug;18(8):1595-601",mammary gland integrity trait,,RS:0000032,ACI/SegHsd,female,260 days to 160 days,21,,CMO:0000345,post-insult time to mammary tumor formation,,,median,143,d,,,MMO:0000158,manual palpation method,mammary gland,0.0,,,,,17 beta-estradiol (27.5 mg) (between 99 and 197 days),66111,17 beta-estradiol (27.5 mg) (between 99 and 197 days) 81,"Schaffer BS, et al., Cancer Res. 2006 Aug 1;66(15):7793-800",mammary gland integrity trait,,RS:0000032,ACI/SegHsd,female,259 days to 143 days,22,,CMO:0000345,post-insult time to mammary tumor formation,,,median,133,d,,,MMO:0000158,manual palpation method,,0,,crystalline implant,,,17 beta-estradiol (27.5 mg) (between 193 and 199 days),65763,17 beta-estradiol (27.5 mg) (between 193 and 199 days)